The impact of treatment-resistant depression on the lives of carers: A mixed-methods study

被引:7
|
作者
Denee, Tom [1 ,9 ]
Kerr, Cicely [1 ]
Eva, Joe [2 ]
Vincent, Sally-Anne [2 ]
Jacobsen, Nicholas [4 ]
Young, Allan H. [3 ,7 ,8 ]
Desai, Mitesh [5 ]
Baldock, Laura [2 ]
Rathod, Shanaya [6 ]
机构
[1] Janssen Cilag Ltd, High Wycombe, Bucks, England
[2] OPEN VIE Ltd, OPEN Hlth, Marlow, England
[3] Inst Psychiat Psychol & Neurosci, Dept Psychol Med, London, England
[4] Newquay Hlth Ctr, Newquay, England
[5] MD3 Consulting Ltd, High Wycombe, Bucks, England
[6] Southern Hlth NHS Fdn Trust, Southampton, England
[7] South London & Maudsley NHS Fdn Trust, London, England
[8] Bethlem Royal & Maudsley Hosp, Beckenham, England
[9] Janssen Cilag Ltd, 50-100 Holmers Farm Way, High Wycombe HP12 4EG, Bucks, England
关键词
Treatment -resistant depression; Carer impact; Health -related quality of life; Productivity; Qualitative research; Mixed methods; LIFE; CAREGIVERS; FAMILIES; EUROQOL;
D O I
10.1016/j.jad.2022.12.135
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Introduction: The lived experiences of informal carers of people with depression, particularly those with treatment-resistant depression (TRD), are rarely explored, despite their vital supportive role. Methods: This mixed-methods study explored the quality of life (QoL) and experiences of carers of individuals with symptomatic TRD (Carers-Sym-TRD; n = 79) or in remission post-TRD (Carers-Rem-TRD; n = 20). Participating carers completed quantitative surveys measuring health-related and broader QoL (EQ-5D-5L/ WHOQOL-BREF) and work productivity/activity impairment (WPAI:MM-CG). Interviews were also conducted with 12 Carers-Sym-TRD and 11 Carers-Rem-TRD and analysed thematically. Results: Carers-Sym-TRD had impaired QoL compared with Carers-Rem-TRD, with significantly lower EQ-5D-5L index values (median = 0.84/1.00, respectively; p = 0.020) and WHOQOL-BREF overall score (median = 63.0/ 70.1; p < 0.001), physical health (median = 15.3/17.3; p < 0.001), psychological health (median =13.3/14.7; p = 0.017), social relationships (median = 13.3/14.7; p = 0.017) and environment (median = 14.5/16.5; p = 0.011) domain scores. Work productivity/activity impairment was greatest in Carers-Sym-TRD across most WPAI:MM-CG domains, with a higher degree of impairment reported on the presenteeism and work productivity domains, however, there were no significant differences between the carer groups. Interview data suggested that impacts on carers' psychological/emotional wellbeing led to physical problems, which affected cognition and daily performance; Also, successful treatment for the person with depression helped carers worry less and reclaim their independence. Limitations: Recruitment challenges limited the Carers-Rem-TRD sample; clinical validation of the patient's depression diagnosis was not confirmed for all carers. Conclusions: TRD has an extensive adverse impact on carers' lives. Carers-Sym-TRD had significantly impaired QoL across a variety of domains compared with Carers-Rem-TRD, suggesting that achieving remission not only benefits patients but also those who care for them.
引用
收藏
页码:194 / 205
页数:12
相关论文
共 50 条
  • [41] Brain stimulation therapies for treatment-resistant depression
    Vitalucci, Alberto
    Coppola, Isabella
    Mirra, Marta
    Maina, Giuseppe
    Bogetto, Filippo
    RIVISTA DI PSICHIATRIA, 2013, 48 (03) : 175 - 181
  • [42] Treatment-resistant depression and axis II comorbidity
    Petersen, T
    Hughes, M
    Papakostas, GI
    Kant, A
    Fava, M
    Rosenbaum, JF
    Nierenberg, AA
    PSYCHOTHERAPY AND PSYCHOSOMATICS, 2002, 71 (05) : 269 - 274
  • [43] Esketamine: a glimmer of hope in treatment-resistant depression
    Upinder Kaur
    Bhairav Kumar Pathak
    Amit Singh
    Sankha Shubhra Chakrabarti
    European Archives of Psychiatry and Clinical Neuroscience, 2021, 271 : 417 - 429
  • [44] Maintenance Ketamine Therapy for Treatment-Resistant Depression
    Archer, Shaina
    Chrenek, Carson
    Swainson, Jennifer
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2018, 38 (04) : 380 - 384
  • [45] Dietary Patterns of Treatment-Resistant Depression Patients
    Mechlinska, Agnieszka
    Wlodarczyk, Adam
    Gruchala-Niedoszytko, Marta
    Malgorzewicz, Sylwia
    Cubala, Wieslaw Jerzy
    NUTRIENTS, 2022, 14 (18)
  • [46] Magnesium in Ketamine Administration in Treatment-Resistant Depression
    Gorska, Natalia
    Cubala, Wieslaw Jerzy
    Slupski, Jakub
    Wiglusz, Mariusz Stanislaw
    Galuszko-Wegielnik, Maria
    Kawka, Mateusz
    Grzegorzewska, Agata
    PHARMACEUTICALS, 2021, 14 (05)
  • [47] The role of intranasal esketamine in treatment-resistant depression
    Fraga, A.
    Esteves-Sousa, D.
    Facucho-Oliveira, J.
    Albuquerque, M.
    Costa, M.
    Espada-Santos, P.
    Moutinho, A.
    EUROPEAN PSYCHIATRY, 2021, 64 : S478 - S479
  • [48] Esketamine: a glimmer of hope in treatment-resistant depression
    Kaur, Upinder
    Pathak, Bhairav Kumar
    Singh, Amit
    Chakrabarti, Sankha Shubhra
    EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE, 2021, 271 (03) : 417 - 429
  • [49] Esketamine: A Novel Option for Treatment-Resistant Depression
    Bozymski, Kevin M.
    Crouse, Ericka L.
    Titus-Lay, Erika N.
    Ott, Carol A.
    Nofziger, Jill L.
    Kirkwood, Cynthia K.
    ANNALS OF PHARMACOTHERAPY, 2020, 54 (06) : 567 - 576
  • [50] Possible usefulness of tianeptine in treatment-resistant depression
    Tobe, Edward H.
    Rybakowski, Janusz K.
    INTERNATIONAL JOURNAL OF PSYCHIATRY IN CLINICAL PRACTICE, 2013, 17 (04) : 313 - 316